Evelo Biosciences, Inc.
NASDAQ:EVLO
0.0004 (USD) • At close November 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.793 | 1.616 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.793 | -1.616 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 6.499 | 13.043 | 17.857 | 16.084 | 21.928 | 21.221 | 19.321 | 18.881 | 22.599 | 20.655 | 21.508 | 22.113 | 14.91 | 15.174 | 17.419 | 16.377 | 15.61 | 15.464 | 15.68 | 11.343 | 11.227 | 10.172 | 7.143 | 6.076 | 5.345 | 4.69 | 3.846 |
| General & Administrative Expenses
| 3.891 | 4.915 | 7.043 | 5.003 | 7.126 | 8.366 | 9.417 | 8.678 | 10.111 | 7.001 | 5.963 | 6.085 | 5.272 | 5.071 | 5.842 | 6.293 | 5.886 | 5.923 | 5.124 | 4.65 | 5.23 | 5.056 | 3.282 | 1.991 | 2.693 | 1.528 | 1.362 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 3.891 | 4.915 | 7.043 | 5.003 | 7.126 | 8.366 | 9.417 | 8.678 | 10.111 | 7.001 | 5.963 | 6.085 | 5.272 | 5.071 | 5.842 | 6.293 | 5.886 | 5.923 | 5.124 | 4.65 | 5.23 | 5.056 | 3.282 | 1.991 | 2.693 | 1.528 | 1.362 |
| Other Expenses
| -0.027 | 0.069 | 0.188 | 0.447 | -0.615 | 0.209 | 0.02 | 0.014 | 0.159 | 0.151 | 0.162 | -0.664 | 0.039 | 0.14 | 0.466 | 0.261 | -0.218 | 0.446 | 0.505 | 0.55 | 0 | -0.285 | -0.121 | -0.077 | -0.066 | -0.068 | -0.09 |
| Operating Expenses
| 10.39 | 17.958 | 24.9 | 21.087 | 29.054 | 29.587 | 28.738 | 27.559 | 32.71 | 27.656 | 27.471 | 28.198 | 20.182 | 20.245 | 23.261 | 22.67 | 21.496 | 21.387 | 20.804 | 15.993 | 16.457 | 15.228 | 10.425 | 8.067 | 8.038 | 6.218 | 5.208 |
| Operating Income
| -11.183 | -19.574 | -24.9 | -21.087 | -29.054 | -29.587 | -28.738 | -27.559 | -32.71 | -27.656 | -27.471 | -28.198 | -20.182 | -20.245 | -23.261 | -22.67 | -21.496 | -21.387 | -20.804 | -15.993 | -16.457 | -15.228 | -10.425 | -8.067 | -8.038 | -6.218 | -5.208 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -1.198 | -1.543 | -0.296 | -1.91 | -0.615 | 0.209 | -1.007 | -0.996 | 0.159 | -3.075 | 0.162 | -0.664 | 0.039 | 0.14 | 0.466 | 0.261 | -0.218 | 0.446 | 0.505 | 0.55 | 0.6 | -0.285 | -0.121 | -0.077 | -0.066 | -0.068 | -0.09 |
| Income Before Tax
| -12.381 | -20.87 | -25.196 | -22.997 | -30.457 | -30.398 | -29.745 | -28.555 | -33.574 | -31.545 | -28.074 | -28.862 | -20.856 | -20.563 | -22.976 | -22.599 | -21.633 | -20.941 | -20.299 | -15.443 | -15.857 | -15.146 | -10.5 | -8.143 | -8.173 | -6.361 | -5.37 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.017 | 0.233 | 0.145 | 0.544 | 0.107 | 0.163 | 0.116 | 0.097 | 0.156 | 0.053 | 0.122 | 0.188 | 0.067 | 0.089 | 0.065 | 0.19 | -0.081 | -0.428 | -0.375 | -0.36 | 0 | -0.367 | -0.046 | -0.001 | 0.069 | 0.075 | 0.072 |
| Net Income
| -12.364 | -21.103 | -25.341 | -23.541 | -30.564 | -30.561 | -29.861 | -28.652 | -33.73 | -31.598 | -28.196 | -29.05 | -20.923 | -20.652 | -23.041 | -22.599 | -21.633 | -20.941 | -20.299 | -15.443 | -15.857 | -15.146 | -10.5 | -8.143 | -8.173 | -6.361 | -5.37 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.71 | -3.78 | -4.57 | -4.29 | -5.66 | -8.07 | -11.14 | -10.71 | -12.63 | -11.84 | -10.98 | -12.44 | -9.07 | -12.66 | -14.29 | -14.09 | -13.5 | -13.07 | -12.72 | -9.72 | -9.99 | -15.44 | -53.57 | -42.63 | -43.47 | -34.2 | -29.51 |
| EPS Diluted
| -0.71 | -3.78 | -4.57 | -4.29 | -5.66 | -8.07 | -11.14 | -10.71 | -12.63 | -11.84 | -10.98 | -12.44 | -9.06 | -12.66 | -14.29 | -14.08 | -13.5 | -13.07 | -12.72 | -9.72 | -9.99 | -15.43 | -53.54 | -42.43 | -43.25 | -34.1 | -29.41 |
| EBITDA
| -11.183 | -17.465 | -24.267 | -20.64 | -29.182 | -28.845 | -28.201 | -27.545 | -31.963 | -26.951 | -26.773 | -28.198 | -19.72 | -19.705 | -22.77 | -22.67 | -21.035 | -21.387 | -20.804 | -15.993 | -16.134 | -14.561 | -9.84 | -7.822 | -7.799 | -6.031 | -5.045 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |